About Neurovalens
Neurovalens is a company based in Belfast (United Kingdom) founded in 2013.. Neurovalens has raised $26.12 million across 8 funding rounds from investors including British Business Bank, Invest Northern Ireland and MedTech Innovator. The company has 22 employees as of January 31, 2022. Neurovalens offers products and services including Modius Sleep and Stimulation Pads. Neurovalens operates in a competitive market with competitors including Noctrix Health, Brain in Hand, Zynex, Trexo Robotics and Neurofenix, among others.
- Headquarter Belfast, United Kingdom
- Employees 22 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurovalens Limited
- Date of Incorporation 12 Apr, 2013
- Jurisdiction BALLYMENA, COUNTY ANTRIM, NORTHERN IRELAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.12 M (USD)
in 8 rounds
-
Latest Funding Round
$8.12 M (USD), Series A
Aug 19, 2025
-
Investors
British Business Bank
& 23 more
-
Employee Count
22
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurovalens
Neurovalens offers a comprehensive portfolio of products and services, including Modius Sleep and Stimulation Pads. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
FDA-cleared noninvasive device for treating chronic insomnia.
Replacement pads for neurostimulation devices to maintain treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of Neurovalens
Neurovalens has successfully raised a total of $26.12M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $8.12 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $8.1M
-
First Round
First Round
(19 Jul 2017)
- Investors Count 24
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series A - Neurovalens | Valuation | IQ Capital | |
| Apr, 2024 | Amount | Series A - Neurovalens | Valuation |
investors |
|
| Dec, 2021 | Amount | Grant - Neurovalens | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neurovalens
Neurovalens has secured backing from 24 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include British Business Bank, Invest Northern Ireland and MedTech Innovator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
|
Founded Year | Domain | Location | |
|
Early-stage investments are provided by Techstart Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on angel investments
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neurovalens
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neurovalens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurovalens Comparisons
Competitors of Neurovalens
Neurovalens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noctrix Health, Brain in Hand, Zynex, Trexo Robotics and Neurofenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable therapeutic devices for neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Assistive technology is developed for impaired executive brain functions.
|
|
| domain | founded_year | HQ Location |
Non-invasive electrotherapy and stroke rehabilitation devices are developed by Zynex.
|
|
| domain | founded_year | HQ Location |
Battery-operated exoskeletons for children with disabilities are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for neurorehabilitation are manufactured for therapy sessions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurovalens
Frequently Asked Questions about Neurovalens
When was Neurovalens founded?
Neurovalens was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Neurovalens located?
Neurovalens is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
Is Neurovalens a funded company?
Neurovalens is a funded company, having raised a total of $26.12M across 8 funding rounds to date. The company's 1st funding round was a Grant of $299.36K, raised on Jul 19, 2017.
How many employees does Neurovalens have?
As of Jan 31, 2022, the latest employee count at Neurovalens is 22.
What does Neurovalens do?
Founded in 2013 in Belfast, United Kingdom, Neurovalens operates in the medical device sector, focusing on neuromodulation technology. A compact headset called Stimu Slim is being developed to target brain areas that suppress appetite and induce metabolic changes in the nervous system. The company addresses obesity through non-invasive interventions and was recognized as Company of the Year at the Invest NI Propel Programme awards.
Who are the top competitors of Neurovalens?
Neurovalens's top competitors include Zynex, Noctrix Health and Brain in Hand.
What products or services does Neurovalens offer?
Neurovalens offers Modius Sleep and Stimulation Pads.
Who are Neurovalens's investors?
Neurovalens has 24 investors. Key investors include British Business Bank, Invest Northern Ireland, MedTech Innovator, Techstart Ventures, and ACF Investors.